# BIOTRONIK Orsiro Pre-Marketing Registration

Study · id `cardio:ct-nct02870985` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02870985](<https://clinicaltrials.gov/study/NCT02870985>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02870985

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 440 participants.

## Technical summary

Registry record NCT02870985. Randomized; single masking; primary purpose treatment. Start 2015-07-14 (actual); primary completion 2017-04-06 (actual). Results posted on 2024-03-04.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 440 participants (enrolled count; ClinicalTrials.gov record NCT02870985, source copy `cardio:ctgov-nct02870985-2024-03-04`, retrieved 2026-10-26)
- Started: 2015-07-14 (actual) (ClinicalTrials.gov record NCT02870985, source copy `cardio:ctgov-nct02870985-2024-03-04`, retrieved 2026-10-26)
- Primary completion: 2017-04-06 (actual) (ClinicalTrials.gov record NCT02870985, source copy `cardio:ctgov-nct02870985-2024-03-04`, retrieved 2026-10-26)
- Completion: 2021-12 (actual) (ClinicalTrials.gov record NCT02870985, source copy `cardio:ctgov-nct02870985-2024-03-04`, retrieved 2026-10-26)
- Results first posted: 2024-03-04 (ClinicalTrials.gov record NCT02870985, source copy `cardio:ctgov-nct02870985-2024-03-04`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02870985, source copy `cardio:ctgov-nct02870985-2024-03-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02870985-2024-03-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: BIOTRONIK Orsiro Pre-Marketing Registration
- Acronym: BIOFLOW-VI
- Condition: Coronary Artery Disease
- Intervention (Device): Coronary Stent
- Lead sponsor: Biotronik (Beijing) Medical Device Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Biotronik (Beijing) Medical Device Ltd. (`cardio:org-biotronik-beijing-medical-device-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial (`cardio:pubmed-32268942`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3198df180c78183772a08adf8f992c6a0e4162e419ad4df09f62adbbf6cf96b1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
